Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001894562-24-000049
Filing Date
2024-12-09
Accepted
2024-12-09 18:23:08
Documents
1
Period of Report
2024-12-05

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1733786581.html 4  
1 FORM 4 wk-form4_1733786581.xml 4 4259
  Complete submission text file 0001894562-24-000049.txt   5675
Mailing Address 900 FIFTH AVENUE #8C NEW YORK NY 10021
Business Address
Gottesdiener Keith Michael (Reporting) CIK: 0001615856 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41536 | Film No.: 241536572

Mailing Address 60 FIRST ST. CAMBRIDGE MA 02141
Business Address 60 FIRST ST. CAMBRIDGE MA 02141 617-465-0013
Prime Medicine, Inc. (Issuer) CIK: 0001894562 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)